ResearcherUniversity of Electronic Science and Technology of ChinaNo recent work listed
Mingfei Li
Matched on ORCID iD 0000-0003-3123-0565; OpenAlex author ID A5100737373.
Their work
Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.
- Pancreatic cancer papers
- 3 (first author 0, last author 3)
- Pancreatic cancer trials
- 0
- Pancreatic cancer grants
- 0
- Labs led
- 1
- Collaborators
- 1
2021: 1 paper · 2022: 1 paper · 2023: 1 paper
Papers 3
- m6A-modified circRNA MYO1C participates in the tumor immune surveillance of pancreatic ductal adenocarcinoma through m6A/PD-L1 manner. Last author DOI 10.1038/s41419-023-05570-0↗
- N6-methyladenosine METTL3-induced circMYO1C accelerates the pancreatic ductal adenocarcinoma tumorigenesis through IGF2BP2/VEGFA manner Last author DOI 10.21203/rs.3.rs-1767579/v1↗
- Novel circular RNA circSLIT2 facilitates the aerobic glycolysis of pancreatic ductal adenocarcinoma via miR-510-5p/c-Myc/LDHA axis. Last author DOI 10.1038/s41419-021-03918-y↗
Closest collaborators
The 1 strongest of 1 ranked by shared papers, trials and grants, with recent and small-team work weighing most.
- Hua Guan · 3 shared papers, 2021–2023
- Paper m6A-modified circRNA MYO1C participates in the tumor immune surveillance of pancreatic ductal adenocarcinoma through m6… DOI 10.1038/s41419-023-05570-0↗
- Paper N6-methyladenosine METTL3-induced circMYO1C accelerates the pancreatic ductal adenocarcinoma tumorigenesis through IGF2… DOI 10.21203/rs.3.rs-1767579/v1↗
- Paper Novel circular RNA circSLIT2 facilitates the aerobic glycolysis of pancreatic ductal adenocarcinoma via miR-510-5p/c-My… DOI 10.1038/s41419-021-03918-y↗
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.